Generic dapagliflozin has been on sale since April 2026, the free AstraZeneca route for new Farxiga patients closed on 1 May, and AstraZeneca now sells the brand direct for $35. Here is every published cash price, dated.
The answer, route by route:
Dapagliflozin is the active ingredient in Farxiga, taken once a day. AstraZeneca says "several generic equivalents for FARXIGA and XIGDUO XR became available" beginning in April 2026, and that is the event that changed the cash price: the same molecule now has a mail-order generic price in single dollars, a brand price AstraZeneca sets at $35, and a federal acquisition cost two orders of magnitude higher. This page sets them side by side for readers paying cash; the choice of brand or generic belongs to the person who prescribes it. Related pages on the diabetes class are saxagliptin cost without insurance and the Jardiance price data.
Yes. Generic dapagliflozin is on sale, and its cheapest published cash price is at Cost Plus Drugs: $7.07 for 30 tablets of 5 mg and $7.43 for 10 mg, each including the $5 dispensing fee. Shipped by standard post, the 10 mg pack is $12.68. A 90-tablet pack of 10 mg is $12.28 before shipping, because the fee is charged once per prescription. Cost Plus also lists dapagliflozin with metformin extended-release from $18.21 for 30 tablets.
AstraZeneca's own direct-purchase page says Farxiga "may be available for direct purchase to eligible patients" at "$35 per 30 tablets", with prescriptions fulfilled by ASPN Pharmacies and delivery to your home or a transfer to a local pharmacy. The page lets you choose commercially insured, government insured or uninsured but does not define eligibility, and its footer reads "Last Updated 8/26". RxGrab's TrumpRx comparison lists the same "from $35/mo" figure for Farxiga; see TrumpRx vs GoodRx. GoodRx and SingleCare pages answered RxGrab with bot challenges on 26 October 2026, so no discount-card price is printed here.
For scale, the NADAC median for brand Farxiga is $12.08 a tablet, which is $362.31 for 30 tablets at what pharmacies pay (as of 14 October 2026), and CMS reports it as 65.7 times the acquisition cost of its generic equivalent by its own brand-to-generic correspondence. The 30-tablet figure is a comparison basis, not a price: it is shown because dapagliflozin is taken once daily. NADAC is not a shelf price.
Not as a new patient. AstraZeneca's AZ&Me page says: "Effective May 1, 2026, AZ&Me no longer accepts new patients for FARXIGA and XIGDUO XR", and that, "as a result of this broad generic availability", both "will be removed from the AZ&Me Prescription Savings Program by the end of 2026". Enrolled patients can continue until 31 December 2026, with the last day to request a refill on 15 December 2026 and "no exceptions or extensions". Contact is 1-800-292-6363, weekdays 9:00 AM to 6:00 PM ET. AstraZeneca also lists independent non-profit foundations on its update page. Three older RxGrab pages still listed Farxiga under AZ&Me; they were corrected on 26 October 2026.
The Farxiga savings card terms read: "Eligible commercially insured patients ... who present this savings card at participating pharmacies will pay as low as $0 per 30-day supply subject to a maximum savings of $175 per 30-day supply. If you pay cash for your prescription, AstraZeneca will pay up to the first $150, and you will be responsible for any remaining balance, for each monthly prescription." The card is "not available for government-insured patients": Medicare Part D, Medicaid, Medigap, VA, DOD and TRICARE enrolees are excluded, and "if you are enrolled in a state or federally funded prescription insurance program, you may not use this savings card even if you elect to be processed as an uninsured (cash-paying) patient" (farxiga.com, 26 October 2026). AstraZeneca can rescind the offer at any time.
CMS's negotiated price for Farxiga under the Medicare Drug Price Negotiation Program is $178.50 for a 30-day supply from 1 January 2026, against a list price of $556 (CMS fact sheet; list price on a 2023 30-day basis). That is the price Medicare's plans pay, not a beneficiary's copay, and it applies to Part D coverage, not to cash buyers. For the programme's other drugs and your plan, see OmniRx's Farxiga assistance page. RxGrab attaches no offer or enrolment link to any Medicare sentence.
Walmart's $4 Prescription Program list, effective 24 March 2025 and read in full on 26 October 2026, does not include dapagliflozin, so a Walmart cash price is a counter quote. CMS's NADAC data lists 40 generic dapagliflozin products (NDCs) with a median of $0.173 a tablet and a flat spread (10th to 90th percentile $0.163 to $0.184), so the acquisition cost does not vary much by supplier; the cash prices differ because of fees and shipping. Our brand vs generic price gap study explains the CMS brand-to-generic correspondence behind the 65.7 times above. To check a pharmacy near you use the RxGrab pharmacy finder, and for the mail-order terms see our Cost Plus Drugs review.
Paying cash, prescribed generic dapagliflozin
Cost Plus Drugs, 90 tablets if your prescriber writes for them
$12.28 for 90 x 10 mg before shipping against $7.43 for 30; the $5 fee is paid once.
Paying cash, prescribed the brand
AstraZeneca Direct, after checking eligibility
$35 per 30 tablets is the lowest published brand cash price; the page does not define eligible.
Commercially insured
The Farxiga savings card
As low as $0 per 30 days, up to $175 saved; ask whether generic is cheaper on your plan.
On Medicare or Medicaid
Your plan
The card excludes you even for cash; Medicare's 2026 negotiated price is $178.50 but is not your copay.
An AZ&Me patient
Request your last refill by 15 December 2026
Support ends 31 December with no extensions; plan the next step with your prescriber.
1. Is the prescription written for brand Farxiga or generic dapagliflozin, and is a generic acceptable to my prescriber? 2. What is my coverage: commercial, Medicare, Medicaid, VA or TRICARE, or none? (The Farxiga savings card excludes government plans even for cash.) 3. Is the price for 30 tablets, 60 or 90? Is the dispensing fee charged once per prescription? 4. Does the price include shipping? (Cost Plus: $5.25 standard shipping on top.) 5. If I am an AZ&Me patient: have I requested my last refill by 15 December 2026? 6. For AstraZeneca Direct: what does "eligible" mean for me before I place the order?
| Route | Price for 30 tablets | Who it is for | Terms and limits | Read |
|---|---|---|---|---|
| Mark Cuban Cost Plus Drugs | Generic 10 mg $7.43, 5 mg $7.07; $12.68 shipped (10 mg) | Anyone with a prescription for generic dapagliflozin | $5 dispensing fee included; 90 x 10 mg $12.28 before shipping | 26 Oct 2026 |
| AstraZeneca Direct | Brand: "$35 per 30 tablets" | "Eligible patients"; you choose commercial, government or uninsured | Delivered or transferred to a local pharmacy; page footer "Last Updated 8/26" | 26 Oct 2026 |
| Farxiga savings card | As low as $0 per 30-day supply, up to $175 saved; cash buyers: AstraZeneca pays up to the first $150 | Commercially insured patients (cash use also needs no government plan) | Excludes Medicare Part D, Medicaid, VA, DOD, TRICARE, "even if you elect to be processed as an uninsured (cash-paying) patient" | 26 Oct 2026 |
| Free to enrolled patients | Closed to new Farxiga patients since 1 May 2026 | Enrolled patients: refills to 15 Dec, ends 31 Dec 2026 | 26 Oct 2026 | |
| Not listed | List effective 24 Mar 2025, read in full | Ask the counter for a cash price | 26 Oct 2026 | |
| Medicare (negotiated price) | $178.50 per 30-day supply, list $556 | Medicare Part D plans, 2026 | A price Medicare pays; not a beneficiary's copay | 4 Oct 2026 transcription |
Prices as each source publishes them on the date shown. AstraZeneca can change or end its offers without notice. Researchers and other sites can reuse the table under the RxGrab data licence.
How we built this page: we read AstraZeneca Direct's Farxiga page, the Farxiga savings card terms and AZ&Me's home and programme-update pages on 26 October 2026, the Cost Plus Drugs pricing API and Walmart's Prescription Program list the same day, the CMS fact sheet for 2026 negotiated prices as transcribed on 4 October 2026, and the CMS NADAC file as of 14 October 2026, and cite each figure where it appears. We did not buy these medicines or use these services for this page; where a price sits behind a bot wall we say so rather than estimate it. Nothing here is medical advice; do not stop or switch a medicine without your prescriber.
Yes. AstraZeneca says several generic equivalents of Farxiga became available beginning in April 2026. Mark Cuban Cost Plus Drugs lists generic dapagliflozin at $7.43 for 30 tablets of 10 mg and $7.07 for 5 mg including its $5 dispensing fee, and $12.68 for 10 mg with standard shipping (pricing API, 26 October 2026).
AstraZeneca Direct lists Farxiga at "$35 per 30 tablets" for eligible patients, delivered or sent to a local pharmacy; the page does not define who is eligible. For comparison, pharmacies pay about $362.31 for 30 brand tablets in CMS's NADAC data (as of 14 October 2026), which is not a shelf price.
Not as a new patient. AstraZeneca's AZ&Me stopped accepting new Farxiga and Xigduo XR patients on 1 May 2026. Enrolled patients can request refills until 15 December 2026 and support ends 31 December 2026, with no exceptions or extensions (azandmeapp.com, 26 October 2026).
For cash buyers who are not in a government plan, the card terms say AstraZeneca will pay up to the first $150 of the cash price. The card excludes Medicare Part D, Medicaid, Medigap, VA, DOD and TRICARE patients even if they choose to pay cash (farxiga.com, 26 October 2026).
CMS's negotiated price for Farxiga for 2026 is $178.50 for a 30-day supply against a list price of $556. That is the price Medicare's plans pay, not what a beneficiary pays, and it does not apply to cash purchases.
No. Walmart's Prescription Program list, effective 24 March 2025, does not include dapagliflozin (RxGrab read the list in full on 26 October 2026), so a Walmart cash price is a counter quote.
We have not started sending yet. Join the list and we will only email when we do.